Combination therapy with sulodexide and a blood pressure...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/737 (2006.01) A61K 31/727 (2006.01) A61K 31/728 (2006.01)

Patent

CA 2606880

The present invention is directed to a method of treating patients suffering from nephropathy of diabetic origin by administration of sulodexide in combination with a blood pressure reducing agent, such as an inhibitor of an angiotensin converting enzyme (ACE inhibitor) and/or with an angiotensin II receptor blocker (ARB). The effectiveness of sulodexide with an ACE inhibitor or an ARB has been shown by the significant decrease of the albuminuria in microalbuminuric diabetic patients.

La présente invention concerne un procédé de traitement de patients souffrant de néphropathie d~origine diabétique en administrant du sulodexide en combinaison avec un agent de réduction de la pression sanguine, tel qu~un inhibiteur d~une enzyme convertissant l~angiotensine (inhibiteur ACE) et/ou avec un bloqueur (ARB) de récepteur de l~angiotensine II. L~efficacité du sulodexide avec un inhibiteur ACE ou un ARB a été montrée au moyen de la diminution significative de l~albuminurie chez les patients diabétiques microalbuminuriques.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Combination therapy with sulodexide and a blood pressure... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Combination therapy with sulodexide and a blood pressure..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Combination therapy with sulodexide and a blood pressure... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1916412

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.